25 April 2023 3 Min Read
Biovac disputes Cipla’s claim it saved government R2.4bn
State-backed vaccine manufacturer says calculation based on inflated demand forecasts and outdated prices
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In